Mankind Pharma Limited (BOM:543904)

Market Cap	910.34B
Revenue (ttm)	135.46B
Net Income (ttm)	17.51B
Shares Out	n/a
EPS (ttm)	42.63
PE Ratio	51.99
Forward PE	39.27
Dividend	1.00 (0.05%)
Ex-Dividend Date	Aug 8, 2025

Volume	6,753
Average Volume	150,282
Open	2,206.05
Previous Close	2,208.35
Day's Range	2,192.00 - 2,214.15
52-Week Range	2,115.50 - 3,050.00
Beta	n/a
RSI	33.20
Earnings Date	Jan 23, 2026

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 26,978
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543904

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.